Bank of Nova Scotia »

Lexicon Pharmaceuticals shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2026-03-31 $115k 74k 1.56

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Key (KEY)
Apple (AAPL)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Cibc Cad (CM)
Alphabet Cap Stk Cl C (GOOG)
Toronto Dominion Bk Ont Com New (TD)
JPMorgan Chase & Co. (JPM)
Bank Of Montreal Cadcom (BMO)
Tesla Motors (TSLA)

View all positions for Bank of Nova Scotia

Top funds holding Lexicon Pharmaceuticals

Artal Group
FMR
Siren
Sessa Capital IM
Vanguard Group
Vanguard Capital Management
Point72 Asset Management
Millennium Management
BlackRock
Jane Street
Geode Capital Management
Susquehanna International
UBS Group
Marshall Wace
Atlantic Trust

View all funds holding Lexicon Pharmaceuticals